An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)
Clinical trial NCT07462130 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07462130
- Sponsor
- Nanjing Chia-tai Tianqing Pharmaceutical
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-05-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.